Geographic analysis of RKIP expression and its clinical relevance in colorectal cancer.
about
Molecular and pathogenetic aspects of tumor budding in colorectal cancermiR-27a regulates cisplatin resistance and metastasis by targeting RKIP in human lung adenocarcinoma cellsRKIP phosphorylation and STAT3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon cancer patients.Heterogeneity analysis of Metastasis Associated in Colon Cancer 1 (MACC1) for survival prognosis of colorectal cancer patients: a retrospective cohort study.Combined evaluation of hexokinase 2 and phosphorylated pyruvate dehydrogenase-E1α in invasive front lesions of colorectal tumors predicts cancer metabolism and patient prognosis.Role of Raf-kinase inhibitor protein in colorectal cancer and its regulation by hydroxycamptothecine.Loss of tapasin correlates with diminished CD8(+) T-cell immunity and prognosis in colorectal cancer.Loss of Raf-1 kinase inhibitor protein (RKIP) is strongly associated with high-grade tumor budding and correlates with an aggressive phenotype in pancreatic ductal adenocarcinoma (PDAC)Tumor budding in upper gastrointestinal carcinomas.RKIP-mediated chemo-immunosensitization of resistant cancer cells via disruption of the NF-κB/Snail/YY1/RKIP resistance-driver loopTumour budding in colorectal cancer: what do we know and what can we do?Understanding perspectives of signalling mechanisms regulating PEBP1 function.Expression of RKIP in chronic myelogenous leukemia K562 cell and inhibits cell proliferation by regulating the ERK/MAPK pathway.The apoptotic and proliferation rate of tumour budding cells in colorectal cancer outlines a heterogeneous population of cells with various impacts on clinical outcome.RKIP: A Key Regulator in Tumor Metastasis Initiation and Resistance to Apoptosis: Therapeutic Targeting and Impact
P2860
Q28085313-8446435F-2292-450F-9924-78F649334DD5Q34151444-91DD96FC-1D5E-41EA-B26C-DDB1EFF37375Q35010521-EA4312A6-F9A8-4060-B7D6-CF59B38F1C36Q35211652-B53D59A9-57EC-4B42-ADEB-6D09E897BC40Q35713627-199FE9AC-826C-4C92-A1BA-E4E79FC2E447Q35852597-6920474C-C607-40ED-9089-8224DF6FA245Q36001921-A8B7EF82-8EF9-47F7-B1B2-9510B34BD5BBQ37501848-9CC9D1AC-C33F-4BFB-A81F-BD6BEBCF3AC4Q38245240-277C7CE6-657A-43CE-B047-66B319B03835Q38322277-226F4BEA-D8C5-47C0-AE60-13923F99F987Q38650462-FC0CB017-056E-4809-809C-1D0669759CB9Q38888382-238CDE66-3701-4422-AF68-F23100ACEB3BQ39161075-9B2C7B08-55EE-4183-97EB-36280D8B060AQ43587615-826B10C2-79C9-4204-A2E4-7ED3FC6676A1Q58704356-9E5543DE-5ADC-4325-8283-6E540DD8CB3C
P2860
Geographic analysis of RKIP expression and its clinical relevance in colorectal cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Geographic analysis of RKIP expression and its clinical relevance in colorectal cancer.
@en
type
label
Geographic analysis of RKIP expression and its clinical relevance in colorectal cancer.
@en
prefLabel
Geographic analysis of RKIP expression and its clinical relevance in colorectal cancer.
@en
P2093
P2860
P356
P1476
Geographic analysis of RKIP expression and its clinical relevance in colorectal cancer
@en
P2093
A Kondi-Pafiti
E Karamitopoulou
P2860
P2888
P304
P356
10.1038/BJC.2013.197
P407
P577
2013-04-30T00:00:00Z